New Zealand Autism Spectrum Disorder Guideline: Supplementary evidence on three pharmacological interventions

This supplementary paper to the New Zealand Autism Spectrum Disorder Guideline considers three pharmacological interventions: aripiprazole, citalopram and melatonin.